Global Cancer Monoclonal Antibodies Pipeline Analysis

Publisher Name :
Date:19-Nov-2013
No. of pages: 660

In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selectively target cancer cells and extract various responses, thus indirectly protecting the non cancerous cells. This characteristic of monoclonal antibodies coupled with increasing potential of the oncology market has made many pharmaceutical giants to invest a significant portion of their R&D on cancer monoclonal antibodies.

In recent years the popularity of monoclonal antibodies has increase many folds as they have revolutionized the treatments for cancer. The applications of Monoclonal antibodies, which are administered intravenously, include cancer cell marking, growth signal blocking, the delivery of chemotherapy toxins, and the reduction of new blood vessel growth. The understanding of these treatments is rapidly becoming an indispensable part of biotech investing, and investors need to clearly understand how monoclonal antibodies are affecting the industry.

“Global Cancer Monoclonal Antibodies Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various Monoclonal Antibodies being developed for the treatment of Cancer. Research report covers all the ongoing Monoclonal Antibodies being developed in various clinical development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the Cancer Monoclonal Antibodies market based upon development process. Following parameters for each Monoclonal Antibodies drug profile in development phase are covered in “Global Cancer Monoclonal Antibodies Pipeline Analysis” research report:

  • Drug Profile Overview
  • Alternate Names for Drug
  • Active Indication
  • Phase of Development
  • Mechanism of Action
  • Brand Name
  • Orphan Designation
  • Patent Information
  • Country for Clinical Trial
  • Owner / Originator/ Licensee/Collaborator
  • Administrative Route
  • Drug Class
  • ATC Codes

Global Cancer Monoclonal Antibodies Drug Pipeline by Clinical Phase:

  • Research: 68
  • Preclinical: 240
  • Phase-I: 112
  • Phase-I/II: 29
  • Phase-II: 73
  • Phase-II/III: 5
  • Phase-III: 31
  • Preregistration: 3
  • Marketed: 27

Global Cancer Monoclonal Antibodies Pipeline Analysis

Table of Contents

1. Global Cancer Monoclonal Antibodies Drug Market

2. Cancer Monoclonal Antibodies Drug Clinical Phase: Research
2.1 Overview
2.2 Cancer Monoclonal Antibodies Drug Profile

3. Cancer Monoclonal Antibodies Drug Clinical Phase: Preclinical
3.1 Overview
3.2 Cancer Monoclonal Antibodies Drug Profile

4. Cancer Monoclonal Antibodies Drug Clinical Phase: Phase-I
4.1 Overview
4.2 Cancer Monoclonal Antibodies Drug Profile

5. Cancer Monoclonal Antibodies Drug Clinical Phase: Phase-I/II
5.1 Overview
5.2 Cancer Monoclonal Antibodies Drug Profile

6. Cancer Monoclonal Antibodies Drug Clinical Phase: Phase-II
6.1 Overview
6.2 Cancer Monoclonal Antibodies Drug Profile

7. Cancer Monoclonal Antibodies Drug Clinical Phase: Phase-II/III
7.1 Overview
7.2 Cancer Monoclonal Antibodies Drug Profile

8. Cancer Monoclonal Antibodies Drug Clinical Phase: Phase-III
8.1 Overview
8.2 Cancer Monoclonal Antibodies Drug Profile

9. Cancer Monoclonal Antibodies Drug Clinical Phase: Preregistration
9.1 Overview
9.2 Cancer Monoclonal Antibodies Drug Profile

10. Marketed
10.1 Overview
10.2 Marketed Cancer Monoclonal Antibodies Drug Profile

List of Tables

Each Drug Profile has Tables Representing Following Information:
Alternate Names
Originator & Owner
Collaborator
Technology Provider
Licensee
Highest Development Phase
Indications
Class
Mechanism of Action
ATC code
Designated Brand Name & Orphan Designation

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Chronic Lymphocytic Leukemia (CLL) Treatment Market worth $3.3 billion by 2018
  • New Entrants to Boost Chronic Lymphocytic Leukemia Treatment Market Value to $3.3 Billion by 2018, says GlobalData. The introduction of several new drugs will accelerate growth in the Chronic Lymphocytic Leukemia (CLL) treatment market, from $1.4 billion in 2013 to …

  • Global Biosimilars Market to Grow at a CAGR of 8.3%, to reach $262 billion by 2019
  • Lucrative Biosimilars Space to Erode Biologics Market from 2019, says GlobalData The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking …

  • Saudi Pharmaceutical Market worth $5.9 billion by 2020
  • A high burden of chronic diseases, improving regulatory guidelines and the launch of new products will provide the necessary impetus for the growth of the pharmaceutical market in Saudi Arabia The Saudi pharmaceutical market is one of the largest markets …

  • B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2014
    Published: 22-Jul-2014        Price: US $2000 Onwards        Pages: 179
    Global Markets Direct's, ‘B-Cell Non-Hodgkin Lymphoma Pipeline Review, H2 2014', provides an overview of the B-Cell Non-Hodgkin Lymphoma's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for B-Cell Non-Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press......
  • Endometrial Cancer – Pipeline Review, H2 2014
    Published: 22-Jul-2014        Price: US $2000 Onwards        Pages: 202
    Global Markets Direct's, ‘Endometrial Cancer Pipeline Review, H2 2014', provides an overview of the Endometrial Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Endometrial Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews ......
  • Hodgkin Lymphoma – Pipeline Review, H2 2014
    Published: 22-Jul-2014        Price: US $2000 Onwards        Pages: 214
    Global Markets Direct's, ‘Hodgkin Lymphoma Pipeline Review, H2 2014', provides an overview of the Hodgkin Lymphoma's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key pl......
  • Brain Cancer – Pipeline Review, H2 2014
    Published: 22-Jul-2014        Price: US $2000 Onwards        Pages: 107
    Global Markets Direct's, ‘Brain Cancer Pipeline Review, H2 2014', provides an overview of the Brain Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Brain Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involv......
  • Fallopian Tube Cancer – Pipeline Review, H2 2014
    Published: 22-Jul-2014        Price: US $2000 Onwards        Pages: 314
    Global Markets Direct's, ‘Fallopian Tube Cancer Pipeline Review, H2 2014', provides an overview of the Fallopian Tube Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Fallopian Tube Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also......
  • Erlotinib – Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)
    Published: 15-Jul-2014        Price: US $1400 Onwards        
    Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know."The most extensive source of patent information available." Product Portfolio Manager - Dr Reddys Laboratories"The database is reliable, frequently updated, well-arranged, user friend......
  • Imatinib – Comprehensive patent search
    Published: 15-Jul-2014        Price: US $7500 Onwards        
    Imagine having your own team of pharmaceutical patent experts at the click of a button.Used by the world's leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are the benchmark in comprehensive, accurate and relevant patent data. Searched and analysed by highly trained, qualified staff using proprietary searching techniques, you won't need to worry about missing patents or updating data. And that means your IP staff will be freed up to concentrate on you......
  • Bevacizumab – Comprehensive patent search
    Published: 15-Jul-2014        Price: US $9300 Onwards        
    Imagine having your own team of pharmaceutical patent experts at the click of a button.Used by the world's leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are the benchmark in comprehensive, accurate and relevant patent data. Searched and analysed by highly trained, qualified staff using proprietary searching techniques, you won't need to worry about missing patents or updating data. And that means your IP staff will be freed up to concentrate on you......
  • Palonosetron – Comprehensive patent search
    Published: 15-Jul-2014        Price: US $7500 Onwards        
    Imagine having your own team of pharmaceutical patent experts at the click of a button.Used by the world's leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are the benchmark in comprehensive, accurate and relevant patent data. Searched and analysed by highly trained, qualified staff using proprietary searching techniques, you won't need to worry about missing patents or updating data. And that means your IP staff will be freed up to concentrate on you......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs